Effectiveness of Institutional Versus Domiciliary Implementation of Standard Pulmonary Rehabilitation Module in Bhopal Gas Exposed Survivors having COPD
Received: 14-Sep-2019 / Accepted Date: 01-Oct-2019 / Published Date: 08-Oct-2019
Abstract
Pulmonary Rehabilitation (PR) is beneficial treatment to decrease symptoms, increase participation and to reduce health costs for COPD patients for improving health quality. Our study compared the impact of pulmonary rehabilitation of gas exposed surviving COPD patients in ameliorating their health status in two operational settings i.e. supervised institutional and unsupervised home based.
The study sample used for PR was 180 gas exposed COPD subjects in age 40-75 yrs. of both gender, satisfying the inclusion (FEV1 of less than 60% and with no active heart disease) and exclusion criteria which was randomized equally into two groups (institutional and domiciliary). Before starting PR program, a 6 Minute Walk Test (MWT), SGRQ score and PFT was done and the same was assessed every 6 months interval. PR program for 1 hr consisted of breathing exercise, pursed lip breathing, huffing and coughing, diaphragmatic and incentive spirometry technique, active range of movements of all upper and lower limb joints and postural drainage.
Descriptive statistics of 6MWT with SpO2, Pulse rate and distance walked by both groups after interval of 6 months and 12 months of PR shows significant improvement in institutional group as compared to domiciliary. There is no significant difference in the FEV1 values at 6 months in both the groups but at 12th month follow up there is a significant reduction of 0.04 units in the FEV1 values in the domiciliary group as compared to baseline. Analysis of quality of life assessment by SGRQ shows decrease in severity of symptoms score, marked improvement in activity score, impact scores and total scores in Institutional Group after 12 months of Pulmonary Rehabilitation. Improvement in Quality of life and functional exercise capacity is significantly higher in Institutional group as compared to domiciliary group.
Keywords: COPD; PR; 6MWT; SGRQ; FEV1; PFT
Introduction
Pulmonary Rehabilitation is known to be evidence based comprehensive intervention module which is beneficial treatment to decrease symptoms, increase participation and to reduce health costs for COPD patients [1]. COPD patients experience reduced exercise capacity and activity limitation which is a major determinant of impaired quality of life. Pulmonary Rehabilitation has shown to improve exercise capacity, breathlessness and quality of life [2].
Various randomized controlled trials have shown the effectiveness of pulmonary rehabilitation for COPD patients [1-3]. Ries et al. studied 119 COPD patients comparing the effect of a comprehensive pulmonary rehabilitation program and education alone (control group) that showed significant benefits of comprehensive pulmonary rehabilitation in improving exercise performance and important respiratory symptoms [4]. Cochrane Meta-analysis examined the effect of 23 randomized trials [5]. It was seen that pulmonary rehabilitation for COPD improves dysponea and disease specific quality of life. Functional exercise capacity as assessed by 6 minute walk distance was also increased by 49 m. The benefits were more in severe COPD as compared to mild and moderate disease and effects were maintained for up to 6 months. A few other studies have found reduction in anxiety and depression after pulmonary rehabilitation in patients with COPD [6-8].
One clinical study using tiotropium has shown that a better outcome of pulmonary rehabilitation can be obtained using this therapy [9]. An analysis of pooled data from number of trials demonstrated that pulmonary rehabilitation improved the endurance time during a constant work-rate by an average of 87%, peak work rate by an average of 18%, peak oxygen uptake by 11% compared with pre rehabilitation levels [10]. The American College of Physicians (ACP) guidelines recommend that prescribing pulmonary rehabilitation in symptomatic individuals with COPD( FEV1 less than 50% predicted) which contrasts with ATS/ERS guidelines suggesting pulmonary rehabilitation may be started from an earlier stage [11]. Studies have shown that pulmonary rehabilitation is important for patients with idiopathic pulmonary fibrosis and interstitial lung disease [12,13]. An Indian study found 6 weeks of home based pulmonary rehabilitations program effective in increasing exercise endurance in patients with ILD [14]. Another study of seven weeks of PR showed greater benefit as compared to four weeks [15].
Individuals exposed to MIC in Bhopal have chronic persistent inflammatory changes in the lower respiratory tract [16]. In addition, a proportion of subjects exposed to MIC have persisting airflow limitation that is indistinguishable from COPD [17]. As pulmonary rehabilitation is a life-long process, emphasis was made to develop community based PR programs near the residences of such patients so that continuous rehabilitation and better participation was achieved. This study has compared the impact of Pulmonary Rehabilitation to gas exposed surviving COPD patients in ameliorating their health status in two operational settings i.e. supervised institutional and unsupervised home based.
Methods
The study was carried out at Pulmonary Rehabilitation center established in Jawaharlal Nehru, Gas Rahat Hospital, Bhopal, located near severely gas exposed localities to facilitate easy accessibility and participation of COPD subjects for pulmonary rehabilitation.
The study subjects were confirmed COPD cases in 40-75 years of both sexes selected from the gas exposed population satisfying the inclusion and exclusion criteria. Inclusion criteria were confirmed diagnosis of COPD, Forced expiratory volume in 1 sec (FEV1) of less than 60% and with no active heart disease.
Ethical Committee approved the research project. The subjects included in the rehabilitation group were treated with the standard COPD medications as per GOLD criteria and given one week training of pulmonary rehabilitation at Institutional Centre. Before starting pulmonary rehabilitation a 6 minute Walk test, SGRQ score and PFT was done. Written consent was obtained from participating subjects. Randomization of 180 gas exposed COPD subjects into two groups Institutional and Domiciliary was completed.
The rehabilitation program consisted of breathing exercise pursed lip breathing, huffing and coughing, diaphragmatic and incentive spirometry technique, active range of movements of all upper and lower limb joints and postural drainage.
Subjects in the Institutional group underwent pulmonary rehabilitation daily for one hour duration at pulmonary rehabilitation center under the supervision of qualified Physiotherapist and criteria of attendance (85%-90%) was fixed for successful completion of pulmonary rehabilitation. Domiciliary group undertook same exercises for one hour duration at their residences. Follow up at interval of 6 months and 12 months was repeated.
Six-minute walking test (6MWT)
The 6MWT was administered to study subjects as per procedure recommended by American Thoracic Society (ATS) guidelines in an enclosed corridor [18].
Pulmonary function testing
Spirometry and flow volumes were measured by Jaegers master screen unit.
St. George Respiratory Questionnaire (SGRQ)
The SGRQ Questionnaire is designed to measure health impairment in COPD patients. Three component scores were calculated; Symptoms, Activity, Impact. One total score is also calculated [19]. The questionnaire is designed for supervised self-administration by patients. It is to elicit patient’s opinion of his/her health. Assessment and evaluation of any subjective symptom is difficult task and it typically relies on as self-reported by patients.
Sample size
A total of 180 diagnosed COPD subjects among the toxic gas exposed cohort in Bhopal were enrolled for rehabilitation program. This sample size is sufficient to have 99% confidence and 80% power of the study. The sample size is arrived at on the basis of significant difference (p<0.05, paired t-test) found in the pulse rate before and after pulmonary physiotherapy in a pilot study on 19 COPD subjects.
Results
The first two rounds of six monthly follow up of both the study groups (Institutional and domiciliary) was completed.
In the 6MWT the Baseline values of SpO2, Pulse rate, Distance in two groups were similar initially but after 12 months of PR the institutional group had distance of 217.24 m as compared to domiciliary group of 167.28 m with difference of 49.96 m.
Mean age group of institutional group was 58.03 yrs and domiciliary group was 59.57 yrs. Details are shown in Table 1.
Group | Baseline | 6 month | 12 month | |||||||
---|---|---|---|---|---|---|---|---|---|---|
N | Pre 6MWT | Post 6MWT | N | Pre 6MWT | Post 6MWT | N | Pre 6MWT | Post 6MWT | ||
SPO2 (%) | Institutional | 90 | 93.38 (1.16) | 92.48 (1.59) | 86 | 94.29 (2.12) | 93.30 (2.18) | 86 | 94.93 (0.89) | 94.43 (0.99) |
Domiciliary | 90 | 93.16 (1.36) | 92.14 (1.80) | 84 | 94.21 (1.12) | 93.36 (1.34) | 84 | 94.43 (0.88) | 93.69 (1.14) | |
PR (BPM) | Institutional | 90 | 87.81 (8.24) | 100.02 (9.67) | 86 | 85.51 (7.62) | 95.26 (8.01) | 86 | 82.01 (5.17) | 94.98 (5.89) |
Domiciliary | 90 | 87.62 (8.69) | 99.40 (9.66) | 84 | 85.29 (7.76) | 95.62 (8.55) | 84 | 81.63 (4.80) | 93.92 (5.74) | |
Distance (MTR) | Institutional | 90 | 139.4651 (18.54324) | 86 | 151.7558 (19.64625) | 86 | 217.2442 (28.57351) | |||
Domiciliary | 90 | 138.8721 (20.48632) | 84 | 151.1667 (20.44377) | 84 | 167.2857 (20.41) | ||||
Age | Institutional | 90 | 58.03 (8.14) | |||||||
Domiciliary | 90 | 59.57 (7.40) | ||||||||
Gender (Male): n(%) | Institutional | 90 | 53 (61.63%) | |||||||
Domiciliary | 90 | 48 (55.81%) |
Table 1: Descriptive statistics: 6 MWT. Provided mean (SD): Descriptive statistics of 6 Minute Walk Test of variable oxygen saturation level (SpO2). Pulse rate (PR) , Distance, Age and Gender of COPD subjects follow up at 6 months and 12 months interval for pulmonary rehabilitation of Institutional and Domiciliary group after Pulmonary rehabilitation.
For SGRQ scores, the values of symptoms, activity, impact and total were calculated and initially the baseline values were found similar with the institutional and domiciliary groups, but after 12 months follow up the total score for institutional group was 4.49 and for domiciliary group was 71.86, shown in Table 2.
Institutional | Domiciliary | |||||
---|---|---|---|---|---|---|
SGRQ Score Type | Baseline | 6 month | 12 month | Baseline | 6 month | 12 month |
Symptom | 89.48 (2.87) |
76.03 (12.19) |
17.16 (6.40) |
89.13 (2.79) |
75.52 (12.10) |
76.93 (12.74) |
Activity | 98.53 (3.18) |
74.21 (14.62) |
3.83 (-5.41) |
98.17 (3.24) |
71.91 (15.40) |
72.95 (15.67) |
Impact | 99.74 (1.01) |
70.39 (14.10) |
0.9 (-1.13) |
99.72 (0.53) |
70.36 (15.20) |
69.65 (16.45) |
Total | 97.67 (1.86) |
72.49 (11.54) |
4.49 (2.49) |
97.49 (1.67) |
71.69 (11.70) |
71.86 (12.75) |
Table 2: Descriptive Statistics: SGRQ. Provided Mean (SD): Descriptive Statistics St. George respiratory Questionnaire (SGRQ) of COPD subjects of Institutional and Domiciliary group at interval of 6 and 12 months after Pulmonary rehabilitation.
PFT showing FEV1 (post broncho-dilatation) in institutional group was maintained from 1.05 L to 1.04 L at 12 months follow up while domiciliary group FEV1 dropped from 1.03 L to 1.01 L (Table 3).
Baseline | 6 month | 12 month | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Group | N | Pre bronchodilator | Post Bronchodilator | N | Pre bronchodilator | Post Bronchodilator | N | Pre bronchodilator | Post Bronchodilator | |
Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | |||||||
FEV1 | Institutional | 86 | 0.91 (0.34) | 1.05 (0.36) | 86 | 0.92 (0.33) | 1.05 (0.36) | 86 | 0.91 (0.33) | 1.04 (0.36) |
Domiciliary | 86 | 0.93 (0.35) | 1.03 (0.35) | 84 | 0.94 (0.34) | 1.05 (0.35) | 84 | 0.95 (0.37) | 1.01 (0.35) |
Table 3: Descriptive statistics: PFT. Provided mean(SD): Spirometry of COPD subjects after undergoing pulmonary rehabilitation at interval of 6 and 12 months of Institutional and Domiciliary group.
Comparison of age, sex, BMI, FEV1 with time group shows domiciliary group FEV1 decline by 0.04. Detail comparison of all parameters is shown in Table 4.
Variable | Coefficient | SE | p value | 95% CI |
---|---|---|---|---|
Age | -0.002 | 0.001 | 0.206 | (-0.004, 0.0008) |
Sex: Female | -0.05 | 0.02 | 0.009 | (-0.09, -0.01) |
BMI | 0.003 | 0.002 | 0.166 | (-0.001, 0.006) |
FEV 1: Pre bronchodilator | 0.83 | 0.03 | 0.000 | (0.78, 0.88) |
Group: Domiciliary | -0.02 | 0.02 | 0.245 | (-0.07, 0.02) |
Time*Group: | ||||
6 month* Institutional | -0.001 | 0.01 | 0.923 | (-0.03, 0.02) |
6 month* Domiciliary | 0.02 | 0.01 | 0.224 | (-0.01, 0.04) |
12 month* Institutional | -0.01 | 0.01 | 0.471 | (-0.03, 0.02) |
12 month*Domiciliary | -0.04 | 0.01 | 0.001 | (-0.07, -0.02) |
Table 4: FEV1. Comparison of Age, Sex, BMI and Forced expiratory vol. in 1 sec. (FEV1) of Institutional and Domiciliary groups at interval of 6 and 12 months after pulmonary rehabilitation.
Statistical methods
To summarize the continuous variables we used mean and standard deviation and frequency with percentage was used to summarize the categorical variables. As pulmonary rehabilitation is a longitudinal study observes subjects over time, we used Generalized Estimating Equation (GEE) for studying the change in FEV1, SpO2, PR, Distance walked, SGRQ score (Symptom score, Activity score, Impact score and Total score) between Institutional vs Domiciliary group in the population over time after adjusting for other confounding variables such as age, gender and BMI. P value<0.05 was considered for statistical significance.
Discussion
The participants of both the groups were assessed at baseline, after interval of 6months and 12 months of pulmonary rehabilitation program. The variables considered for statistical analysis included functional exercise capacity by six minute walk test (6MWT), quality of life assessment by SGRQ and spirometry values. Variables were compared between the Institutional and Domiciliary group after Pulmonary Rehabilitation. Descriptive statistics of 6MWT with SpO2, PR, Distance as variables of COPD subjects undergoing pulmonary rehabilitation of both groups at baseline, 6 months, 12 months interval period shows improvement of distance walked in both the groups but significant improvement in Institutional versus Domiciliary group (Table 1). Analysis of quality of life assessment by SGRQ shows decrease in severity of symptoms score, marked improvement in activity score, impact scores and total scores in Institutional Group after 12 months of Pulmonary Rehabilitation (Table 2) .There is no significant difference in the FEV1 values at 6 months in both the groups as compared to baseline (Table 3). The progressive decline in pulmonary function found in COPD patients is considered a major prognostic factor of the course of the disease. After 12 months follow up of Pulmonary Rehabilitation there is a significant reduction of 0.04 units in the FEV1 values in the domiciliary group as compared to baseline after adjusting all other confounding variables in the model (p value=0.001), (Table 4) while the Institutional group has maintained the baseline value of FEV1. Thus, the Improvement in Quality of life and functional exercise capacity is significantly higher in Institutional group as compared to domiciliary group.
Conclusion
The study concluded that the supervised institutional group was found to be more beneficial than unsupervised domiciliary group in the rehabilitation program to improve the quality of life in gas exposed COPD subjects. Hence, Community based pulmonary rehabilitation units are better compliances for easy accessibility and subject participation for COPD cases.
Acknowledgment
Authors acknowledge the Indian Council of Medical Research, Government of India, New Delhi, for providing necessary financial support.
References
- Ries AL, Bauldoff GS, Carlin BW, Casaburi R, Emery CF, et al. (2007) Pulmonary rehabilitation: Joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest 131: 4-42.
- Goldstein RS, Gort EH, Avendano MA, Stubbing D, Guyatt GH (1994) Randomised controlled trial of respiratory rehabilitation. The Lancet 344: 1394-1397
- Griffiths TL, Phillips CJ, Davies S, Burr ML, Campbell IA (2001) Cost effectiveness of an outpatient multidisciplinary pulmonary rehabilitation programme. Thorax 56: 779-784.
- Wedzicha JA, Bestall JC, Garrod R, Garnham R, Paul EA, et al. (1998) Randomized controlled trial of pulmonary rehabilitation in severe chronic obstructive pulmonary disease patients, stratified with the MRC dyspnoea scale. Eur Respir J 12: 363-369.
- Güell R, Casan P, Belda J, Sangenis M, Morante F, et al. (2000) Long-term effects of outpatient rehabilitation of COPD: A randomized trial. Chest 117: 976-983.
- Troosters T, Gosselink R, Decramer M (2000) Short-and long-term effects of outpatient rehabilitation in patients with chronic obstructive pulmonary disease: A randomized trial. Am J Med 109: 207-212.
- Ries AL, Kaplan RM, Limberg TM, Prewitt LM (1995) Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med 122: 823-832.
- McCarthy B, Casey D, Devane D, Murphy K, Murphy E, et al. (2015)Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 13: 1-5.
- Güell R, Resqueti V, Sangenis M, Morante F, Martorell B, et al. (2006) Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest 129: 899-904.
- Godoy RF de, Teixeira PJZ, Becker Júnior B, Michelli M, Godoy DV de (2009) Long-term repercussions of a pulmonary rehabilitation program on the indices of anxiety, depression, quality of life and physical performance in patients with COPD. J Bras Pneumol 35: 129-136.
- Swigris JJ, Fairclough DL, Morrison M, Make B, Kozora E, et al. (2011) Benefits of pulmonary rehabilitation in idiopathic pulmonary fibrosis. Respir Care 56: 783-789.
- Markovitz GH, Cooper CB (2010) Review series: Rehabilitation in non COPD: Mechanisms of exercise limitation and pulmonary rehabilitation for patients with pulmonary fibrosis/restrictive lung disease. Chron Respir Dis 7: 47-60.
- Nici L, Donner C, Wouters E, Zuwallack R, Ambrosino N, et al. (2006) American thoracic society/European respiratory society statement on pulmonary rehabilitation. Am J Respir Crit Care Med 173: 1390-1413.
- Green RH, Singh SJ, Williams J, Morgan MDL (2001) A randomised controlled trial of four weeks versus seven weeks of pulmonary rehabilitation in chronic obstructive pulmonary disease. Thorax 56: 143-145.
- Vijayan VK, Sankaran K (1996) Relationship between lung inflammation, changes in lung function and severity of exposure in victims of the Bhopal tragedy. Eur Respir J 9: 1977-1982.
- Cullinan P, Acquilla S, Dhara VR (1997) Respiratory morbidity 10 years after the Union Carbide gas leak at Bhopal: A cross sectional survey. Bmj 314: 338.
- Society AT (2002) ATS statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med 166: 111-117.
- Jones PW, Quirk FH, Baveystock CM (1991) The St George’s respiratory questionnaire. Respir Med 85: 25-31.
Citation: Galgalekar R, Devika S, Rana S, Kumar L, Rathore M (2019) Effectiveness of Institutional Versus Domiciliary Implementation of Standard Pulmonary Rehabilitation Module in Bhopal Gas Exposed Survivors having COPD. J Card Pulm Rehabil 3: 125.
Copyright: © 2019 Galgalekar R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Open Access Journals
Article Usage
- Total views: 2162
- [From(publication date): 0-2019 - Nov 21, 2024]
- Breakdown by view type
- HTML page views: 1565
- PDF downloads: 597